Headache Impact Test News Today

Teva Pharmaceutical Industries Limited announced that data from the UNITE study presented at the World Congress of Neurology in Montreal, Canada, show that AJOVY® reduced migraine attacks and...

Italian researchers find that ketogenic diets not only reduce the frequency and intensity of migraines but also significantly alleviate fatigue in sufferers. The study opens new doors for alternative, diet-based therapies for chronic and high-frequency episodic migraineurs.

For patients with chronic migraine, 4 or fewer headache days per month is a more effective treatment goal than a 50% reduction in headache frequency.

1. Patients with migraines had increased iron deposition in the putamen, caudate, and nucleus accumbens as compared to healthy controls. 2. Higher volumes of iron deposition were significantly associated with disease progression and disease burden. Evidence Rating Level: 2 (Good) Study Rundown: Migraine is a widespread condition that has significant socioeconomic impact. Patients

Patients with migraine have elevated serum levels of GDF-15 and FGF-21, with these higher concentrations linked to greater severity.

Eptinezumab is associated with clinically meaningful and rapid improvements in headache-related life impact in adults with chronic migraine.

Use of a remote electrical neuromodulation device every other day helped patients significantly reduce their number of migraine days compared with a placebo device, in new research.

In a real-world setting, patients with migraine who underwent treatment with erenumab reported high satisfaction and reduced migraine frequency.

Among veterans with comorbid posttraumatic headache and PTSD, cognitive behavioral therapy was a more effective intervention than standard therapies.

Among veterans with comorbid posttraumatic headache and PTSD, cognitive behavioral therapy was a more effective intervention than standard therapies.